Report Detail

Pharma & Healthcare Global Human Parenteral Nutrition Market Growth (Status and Outlook) 2022-2028

  • RnM4488439
  • |
  • 30 August, 2022
  • |
  • Global
  • |
  • 101 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Human Parenteral Nutrition is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Human Parenteral Nutrition market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Human Parenteral Nutrition market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Human Parenteral Nutrition market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Human Parenteral Nutrition market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Human Parenteral Nutrition players cover Baxter, Allergan, Actavis Inc., Otsuka Pharmaceutical Factory, Inc. and Grifols, S.A., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Human Parenteral Nutrition market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Human Parenteral Nutrition market, with both quantitative and qualitative data, to help readers understand how the Human Parenteral Nutrition market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Human Parenteral Nutrition market and forecasts the market size by Type (Carbohydrate Nutrition, Parenteral Lipid Emulsion Nutrition and Single Dose Amino Acid Solution Nutrition), by Application (Hospital, Clinic and Nursing Home,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Carbohydrate Nutrition
Parenteral Lipid Emulsion Nutrition
Single Dose Amino Acid Solution Nutrition
Trace Element Nutrition
Vitamins & Mineral Nutrition

Segmentation by application
Hospital
Clinic
Nursing Home

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Baxter
Allergan
Actavis Inc.
Otsuka Pharmaceutical Factory, Inc.
Grifols, S.A.
B. Braun Melsungen AG
Vifor Pharma
Fresenius Kabi AG
Sichuan Kelun Pharmaceutical Co., Ltd.
Pfizer Inc. (Hospira Inc.)

Chapter Introduction
Chapter 1: Scope of Human Parenteral Nutrition, Research Methodology, etc.
Chapter 2: Executive Summary, global Human Parenteral Nutrition market size and CAGR, Human Parenteral Nutrition market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Human Parenteral Nutrition revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Human Parenteral Nutrition revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Human Parenteral Nutrition market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Baxter, Allergan, Actavis Inc., Otsuka Pharmaceutical Factory, Inc., Grifols, S.A., B. Braun Melsungen AG, Vifor Pharma, Fresenius Kabi AG and Sichuan Kelun Pharmaceutical Co., Ltd. and etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Human Parenteral Nutrition Market Size 2017-2028
    • 2.1.2 Human Parenteral Nutrition Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Human Parenteral Nutrition Segment by Type
    • 2.2.1 Carbohydrate Nutrition
    • 2.2.2 Parenteral Lipid Emulsion Nutrition
    • 2.2.3 Single Dose Amino Acid Solution Nutrition
    • 2.2.4 Trace Element Nutrition
    • 2.2.5 Vitamins & Mineral Nutrition
  • 2.3 Human Parenteral Nutrition Market Size by Type
    • 2.3.1 Human Parenteral Nutrition Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Human Parenteral Nutrition Market Size Market Share by Type (2017-2022)
  • 2.4 Human Parenteral Nutrition Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Clinic
    • 2.4.3 Nursing Home
  • 2.5 Human Parenteral Nutrition Market Size by Application
    • 2.5.1 Human Parenteral Nutrition Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Human Parenteral Nutrition Market Size Market Share by Application (2017-2022)

3 Human Parenteral Nutrition Market Size by Player

  • 3.1 Human Parenteral Nutrition Market Size Market Share by Players
    • 3.1.1 Global Human Parenteral Nutrition Revenue by Players (2020-2022)
    • 3.1.2 Global Human Parenteral Nutrition Revenue Market Share by Players (2020-2022)
  • 3.2 Global Human Parenteral Nutrition Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Human Parenteral Nutrition by Regions

  • 4.1 Human Parenteral Nutrition Market Size by Regions (2017-2022)
  • 4.2 Americas Human Parenteral Nutrition Market Size Growth (2017-2022)
  • 4.3 APAC Human Parenteral Nutrition Market Size Growth (2017-2022)
  • 4.4 Europe Human Parenteral Nutrition Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Human Parenteral Nutrition Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Human Parenteral Nutrition Market Size by Country (2017-2022)
  • 5.2 Americas Human Parenteral Nutrition Market Size by Type (2017-2022)
  • 5.3 Americas Human Parenteral Nutrition Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Human Parenteral Nutrition Market Size by Region (2017-2022)
  • 6.2 APAC Human Parenteral Nutrition Market Size by Type (2017-2022)
  • 6.3 APAC Human Parenteral Nutrition Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Human Parenteral Nutrition by Country (2017-2022)
  • 7.2 Europe Human Parenteral Nutrition Market Size by Type (2017-2022)
  • 7.3 Europe Human Parenteral Nutrition Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Human Parenteral Nutrition by Region (2017-2022)
  • 8.2 Middle East & Africa Human Parenteral Nutrition Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Human Parenteral Nutrition Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Human Parenteral Nutrition Market Forecast

  • 10.1 Global Human Parenteral Nutrition Forecast by Regions (2023-2028)
    • 10.1.1 Global Human Parenteral Nutrition Forecast by Regions (2023-2028)
    • 10.1.2 Americas Human Parenteral Nutrition Forecast
    • 10.1.3 APAC Human Parenteral Nutrition Forecast
    • 10.1.4 Europe Human Parenteral Nutrition Forecast
    • 10.1.5 Middle East & Africa Human Parenteral Nutrition Forecast
  • 10.2 Americas Human Parenteral Nutrition Forecast by Country (2023-2028)
    • 10.2.1 United States Human Parenteral Nutrition Market Forecast
    • 10.2.2 Canada Human Parenteral Nutrition Market Forecast
    • 10.2.3 Mexico Human Parenteral Nutrition Market Forecast
    • 10.2.4 Brazil Human Parenteral Nutrition Market Forecast
  • 10.3 APAC Human Parenteral Nutrition Forecast by Region (2023-2028)
    • 10.3.1 China Human Parenteral Nutrition Market Forecast
    • 10.3.2 Japan Human Parenteral Nutrition Market Forecast
    • 10.3.3 Korea Human Parenteral Nutrition Market Forecast
    • 10.3.4 Southeast Asia Human Parenteral Nutrition Market Forecast
    • 10.3.5 India Human Parenteral Nutrition Market Forecast
    • 10.3.6 Australia Human Parenteral Nutrition Market Forecast
  • 10.4 Europe Human Parenteral Nutrition Forecast by Country (2023-2028)
    • 10.4.1 Germany Human Parenteral Nutrition Market Forecast
    • 10.4.2 France Human Parenteral Nutrition Market Forecast
    • 10.4.3 UK Human Parenteral Nutrition Market Forecast
    • 10.4.4 Italy Human Parenteral Nutrition Market Forecast
    • 10.4.5 Russia Human Parenteral Nutrition Market Forecast
  • 10.5 Middle East & Africa Human Parenteral Nutrition Forecast by Region (2023-2028)
    • 10.5.1 Egypt Human Parenteral Nutrition Market Forecast
    • 10.5.2 South Africa Human Parenteral Nutrition Market Forecast
    • 10.5.3 Israel Human Parenteral Nutrition Market Forecast
    • 10.5.4 Turkey Human Parenteral Nutrition Market Forecast
    • 10.5.5 GCC Countries Human Parenteral Nutrition Market Forecast
  • 10.6 Global Human Parenteral Nutrition Forecast by Type (2023-2028)
  • 10.7 Global Human Parenteral Nutrition Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Baxter
    • 11.1.1 Baxter Company Information
    • 11.1.2 Baxter Human Parenteral Nutrition Product Offered
    • 11.1.3 Baxter Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Baxter Main Business Overview
    • 11.1.5 Baxter Latest Developments
  • 11.2 Allergan
    • 11.2.1 Allergan Company Information
    • 11.2.2 Allergan Human Parenteral Nutrition Product Offered
    • 11.2.3 Allergan Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Allergan Main Business Overview
    • 11.2.5 Allergan Latest Developments
  • 11.3 Actavis Inc.
    • 11.3.1 Actavis Inc. Company Information
    • 11.3.2 Actavis Inc. Human Parenteral Nutrition Product Offered
    • 11.3.3 Actavis Inc. Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Actavis Inc. Main Business Overview
    • 11.3.5 Actavis Inc. Latest Developments
  • 11.4 Otsuka Pharmaceutical Factory, Inc.
    • 11.4.1 Otsuka Pharmaceutical Factory, Inc. Company Information
    • 11.4.2 Otsuka Pharmaceutical Factory, Inc. Human Parenteral Nutrition Product Offered
    • 11.4.3 Otsuka Pharmaceutical Factory, Inc. Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Otsuka Pharmaceutical Factory, Inc. Main Business Overview
    • 11.4.5 Otsuka Pharmaceutical Factory, Inc. Latest Developments
  • 11.5 Grifols, S.A.
    • 11.5.1 Grifols, S.A. Company Information
    • 11.5.2 Grifols, S.A. Human Parenteral Nutrition Product Offered
    • 11.5.3 Grifols, S.A. Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Grifols, S.A. Main Business Overview
    • 11.5.5 Grifols, S.A. Latest Developments
  • 11.6 B. Braun Melsungen AG
    • 11.6.1 B. Braun Melsungen AG Company Information
    • 11.6.2 B. Braun Melsungen AG Human Parenteral Nutrition Product Offered
    • 11.6.3 B. Braun Melsungen AG Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 B. Braun Melsungen AG Main Business Overview
    • 11.6.5 B. Braun Melsungen AG Latest Developments
  • 11.7 Vifor Pharma
    • 11.7.1 Vifor Pharma Company Information
    • 11.7.2 Vifor Pharma Human Parenteral Nutrition Product Offered
    • 11.7.3 Vifor Pharma Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Vifor Pharma Main Business Overview
    • 11.7.5 Vifor Pharma Latest Developments
  • 11.8 Fresenius Kabi AG
    • 11.8.1 Fresenius Kabi AG Company Information
    • 11.8.2 Fresenius Kabi AG Human Parenteral Nutrition Product Offered
    • 11.8.3 Fresenius Kabi AG Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Fresenius Kabi AG Main Business Overview
    • 11.8.5 Fresenius Kabi AG Latest Developments
  • 11.9 Sichuan Kelun Pharmaceutical Co., Ltd.
    • 11.9.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
    • 11.9.2 Sichuan Kelun Pharmaceutical Co., Ltd. Human Parenteral Nutrition Product Offered
    • 11.9.3 Sichuan Kelun Pharmaceutical Co., Ltd. Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Sichuan Kelun Pharmaceutical Co., Ltd. Main Business Overview
    • 11.9.5 Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
  • 11.10 Pfizer Inc. (Hospira Inc.)
    • 11.10.1 Pfizer Inc. (Hospira Inc.) Company Information
    • 11.10.2 Pfizer Inc. (Hospira Inc.) Human Parenteral Nutrition Product Offered
    • 11.10.3 Pfizer Inc. (Hospira Inc.) Human Parenteral Nutrition Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Pfizer Inc. (Hospira Inc.) Main Business Overview
    • 11.10.5 Pfizer Inc. (Hospira Inc.) Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Human Parenteral Nutrition. Industry analysis & Market Report on Human Parenteral Nutrition is a syndicated market report, published as Global Human Parenteral Nutrition Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Human Parenteral Nutrition market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,294.00
6,588.00
3,733.20
7,466.40
529,675.20
1,059,350.40
298,253.40
596,506.80
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report